SORT BY Relevancy
In Clinical Air Episode #12, Craig Lipset, Head of Clinical Innovation, R&D, Pfizer talks with Marc Sluijs, Director Life Science Business Development at Oracle Health Sciences.
Marc shares his thoughts on the digital health space and where technology is heading in clinical trials. In this informal discussion, Craig and Marc also cover how digital technologies can better serve patients as well as tips on keeping tabs on this rapidly moving space and what can disrupt pharma?
Head of Clinical Innovation, R&D
Director Life Science Business Development
Oracle Health Sciences
The Conference Forum
This webinar reviews the validation and clinical implementation of BRCAplus, a multi-gene hereditary breast cancer test. Although BRCA1 and BRCA2 account for a large portion of hereditary breast cancer, there are many other genes that differentially impact the risk for breast cancer. BRCAplus was designed to test for mutations in genes that are known to have a high breast cancer risk and that have management guidelines associated with them. With the advent of next-generation sequencing (NGS), it is now possible to test for multiple genes that can increase the risk to develop breast cancer at once.
Donald Jones, Chief Digital Officer, Scripps Translational Science Institute talks with host Craig Lipset, Head of Clinical Innovation, R&D, Pfizer on what's happening with digital in drug development. Don discusses his thoughts on the evolution of new products with digital and the “digitazation” of tools for clinical trials. He also shares his thoughts on the biggest disruptors in pharma.
Don and Craig will be featured in an interview as well at DPharm: Disruptive Innovations to Advance Clinical Trials on September 11, 2014 in Boston.
Head of Clinical Innovation, R&D
Chief Digital Officer
Scripps Translational Science Institute
Founder & Chairman, Wireless Life Sciences Alliance
The Conference Forum
Genetic Counselor Irene Rainville gives a clinical and genetic overview of hereditary sarcoma. She goes over the major sarcoma subtypes, syndromes that have an associated risk of Sarcoma, as well as management approaches and practices.
In Touch Interviews 10-11 a.m. The Clinical Hypnosis Institute will be joining us to discuss their upcoming courses, the variety of hypnosis they offer, what is hypnosis, medical to metaphysical hypnosis, how it can help you and more wonderful topics. Call in with questions. 646-378-0378.
Join host, Craig Lipset, Head of Clinical Innovation, R&D, Pfizer lead a discussion on Investing in the future of clinical research.
Todd Pietri, Co-Founder, Milestone Ventures
Jeremy Sohn, Managing Director, MPM Capital
VC views on:
Disruption in the clinical trial space
Finding opportunities (incubators and accelerators)
Good sources of deal flows
Investing in technology or people?
Beyond the pill
Craig, Todd and Jeremy will also be speaking at Mobile@Dpharm on September 10th at the Farimont Copley Plaza hotel in Boston. This event helps drug developers get their arms around the mobile/digital clinical trial landscape and figure out:
How mobile is innovating clinical trials
What parts of clinical trials mobile/digital technology is currently impacting
How mobile technology is making clinical trials cheaper, easier and more accurate
How mobile/digital is increasing the efficacy of drugs
What the true value is to clinical trials
There is an opportunity to participate in creating a clinical trial app. Mobile@Dpharm will also be of interest to investors and app developers. Following this one day event is DPharm: Disruptive Innovations to Advance Clinical Trials. For more information, visit www.theconferenceforum.org or call 646 350 2580.
In Clinical Air episode # 8, host Craig Lipset, Head of Clinical Innovation, R&D, Pfizer hosts a show discussing investigators as partners in clinical research. Guests include:
Christine Pierre, President, Society of Clinical Research
Jacalyn Kent, Director, Clinical Development Information & Optimization, Eli Lilly
Key topics include:
Misunderstandings around Remote Based Monitoring
Training and communication challenges for remote site managers
What are the real cost savings around RBM...are we just shifting costs?
Real time data and how this should affect sites and payments
Reducing burdens to the sites
Investigator turn over rate, making sites sustainable
Join host, Craig H. Lipset, Head of Clinical Innovation, R&D, Pfizer lead a discussion on what it really means to partner with patients in clinical trials.
Jeri Burtchell, Founder, Partners in Research
Regina Holliday, Artist and Medical Advocate
For more information on Jeri's new launch, visit: Healthivibe.com and for Regina walking gallary, google Regina Holliday, walking gallary.
For more information on the topic of Patients as Partners, visit www.theconferenceforum.org. The Conference Forum presented a program in March 2014 fully dedicated to understanding the journey a patient takes in clinical trials. Also take a look at Disruptive Innovations to Advance Clinical Trials scheduled for September 11-12, 2014 in Boston. This event addresses significant innovation to help improve a patients experience in a clinical trial.
Earlier this week actor/comedian Robin Williams was found dead in his home an apparent suicide. What many people did not realize was that Williams suffered from clinical depression for years. Outwardly the man was all laughs and smiles but on the inside he was fighting a battle for his life. Clinical depression is becoming a more common ailment in today's society, and unfortunately the signs of depression are often missed or ignored. Even though there are celebrities out there who are trying to convince the world it is okay to talk about mental illness the subject is still considered taboo by many.
What IS clinical depression?
Who can be affected by it?
What are the most common treatments?
How common are depression related suicides?
Why does society avoid talking about mental illness?
Can raising awareness make a difference?
Join us on today's show as we attempt to answer these questions and get a dialogue going about mental illness. As always if you wish to call in with your questions or comments phone lines will be open for callers. (646)716-6583
If you can't catch the show live all shows are archived for your listening pleasure.
This show is part of the Leukemia & Lymphoma Society Patient Education Series.
Our special guest is Dr. Christopher Yasenchak from Compass Oncology in Portland, Oregon. Dr. Yasenchak received his M.D. from Pennsylvania State University. He continued his training at the Mayo Clinic College of Medicine and is board certified in hematology, medical oncology and internal medicine. His clinical focus is multiple myeloma, lymphoma, stem cell transplantation, gastrointestinal malignancies and clinical trials.
Mr & Mrs Hypnotist, Beth Bovaird and Paul Irving Beth is a certified hypnotist with the National Guild of Hypnotists and Paul is a certified comedian. Touring from Las Vegas to Boston mixing classic training with their style. They have a background that includes writing, directing, acting, radio hosting and stand up comedy.
Linda Kraan is a Master Consulting Hypnotist, CHt, Past Life Exploration (NGH). Her specialization is in Metaphysical and Spiritual Hypnosis, which includes senior health & palliative care. She also trained as a Laughter Yoga Leader, Reiki Master, Clinical Aromatherapist Reflexologist & Spiritual communicator.
Brenda Pearce, RN is also an author, speaker & healer. She is the host of E Factor Radio and houses a podcast network that can be found at efactorlive.com. Reiki was her opening to greater understanding of all that is possible.
Susan Jennifer Grace is a former college instructor. She is the Director and instructor of Gracehypnosis Training Center, Master Hypnotist, Master Practitioner of Neuro-Linguistic Programming and Autogenics Practitioner/Trainer.